NETCARE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.49 ZAR | +4.77% |
|
-0.92% | -0.62% |
| 05-20 | Transcript : Netcare Limited, H1 2024 Earnings Call, May 20, 2024 | |
| 03-25 | NETCARE LTD: ERICH BOCK, HAS BEEN APPOINTED AS ACTING MANAGING D… | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.95 for the current period. Therefore, the company is undervalued.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.62% | 843M | - | ||
| +18.63% | 85.14B | C+ | ||
| -27.41% | 72.06B | B- | ||
| +2.75% | 27.07B | C+ | ||
| -9.66% | 17.43B | B | ||
| -1.96% | 16.98B | A- | ||
| +3.96% | 16.02B | A- | ||
| +7.75% | 13.87B | B- | ||
| +72.83% | 13.06B | C- | ||
| +72.50% | 12.79B | C+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- NTC Stock
- NTCP Stock
- Ratings Netcare Limited
